Trials / Conditions / Platelet Refractoriness
Platelet Refractoriness
6 registered clinical trials studyying Platelet Refractoriness.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo NCT05284032 | Firas El Chaer, MD | EARLY_Phase 1 |
| Terminated | Administration of Fibrinogen Concentrate for Refractory Bleeding NCT05091684 | Centre Hospitalier Universitaire de Saint Etienne | Phase 2 |
| Terminated | Thrombosomes® in Bleeding Thrombocytopenic Patients Study NCT04631211 | Cellphire Therapeutics, Inc. | Phase 2 |
| Unknown | Platelet Agregation in Patients on ECMO NCT05542134 | University Medical Centre Ljubljana | — |
| Unknown | Platelet Antisedimentation Rate and Multiplate Exams in Patients on Antiplatelet Therapy and Controls NCT03679858 | University of Pecs | — |
| Completed | HPA Antibodies and the Distribution of Antigen and Antibodies NCT03408158 | Guangzhou First People's Hospital | N/A |